The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma is a research paper published in Clinical Lymphoma Myeloma and Leukemia (2019). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.